Fig. 1
Maximum quantity allowed is 999
Please select the quantity
Lysine Specific Demethylase 1-Selective Inhibitor
No.151(August 2013)
- A2411
- N-[(1S)-3-[3-(trans-2-Aminocyclopropyl)phenoxy]-1-(benzylcarbamoyl)propyl]benzamide Hydrochloride (= NCL-1•HCl) (1)
NCL-1, developed by Suzuki, Mizukami, Miyata et al., inhibits lysine specific demethylase 1 (LSD1) which plays a key role in the regulation of gene expression by removing the methyl groups from methylated Lys4 of histone H3 (H3K4) (Fig. 1).1) LSD1 inhibitory activity of NCL-1 was more potent than that of a known LSD1 inhibitor, trans-2-phenylcyclopropylamine. NCL-1 showed H3K4-methylating activity and antiproliferative activity in cellular assays.
This product is a 1:1 mixture of two diastereomers (1R,2S) and (1S,2R) at the trans-cyclopropane ring.
References
- 1)Identification of Cell-Active Lysine Specific Demethylase 1-Selective Inhibitors
- a)R. Ueda, T. Suzuki, K. Mino, H Tsumoto, H. Nakagawa, M. Hasegawa, R. Sasaki, T. Mizukami, N. Miyata, J. Am. Chem. Soc. 2009, 131, 17536.
- b)N. Miyata, T. Suzuki, R. Ueda, T. Mizukami, R. Sasaki, PCT Int. Appl. WO 2010143582, 2010.
- a)R. Ueda, T. Suzuki, K. Mino, H Tsumoto, H. Nakagawa, M. Hasegawa, R. Sasaki, T. Mizukami, N. Miyata, J. Am. Chem. Soc. 2009, 131, 17536.
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.